<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3545">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01894841</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 13-026</org_study_id>
    <nct_id>NCT01894841</nct_id>
  </id_info>
  <brief_title>Veterans Coping Long-term With Active Suicide</brief_title>
  <acronym>CLASP-VA</acronym>
  <official_title>Veterans Coping Long-Term With Suicide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study seeks to test the efficacy of an intervention to reduce suicide behaviors&#xD;
      in Veterans. The Veterans Coping Long Term with Active Suicide Program (CLASP-VA) is an&#xD;
      innovative, telephone-based intervention that combines elements of individual therapy, case&#xD;
      management, and significant other/family therapy and is designed to be integrated into a VA&#xD;
      system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Suicide is a leading cause of death for military personnel, and for the first time in&#xD;
      recorded history, rates of military suicides are exceeding civilian rates. Despite public and&#xD;
      patient health costs associated with suicidal ideation and behavior, existing efforts haven't&#xD;
      appreciably reduced rates of suicidal behavior in the military. Consequently, finding novel,&#xD;
      efficacious, and acceptable methods to reduce suicide behaviors is imperative. The Veteran's&#xD;
      Coping Long Term with Active Suicide Program (CLASP-VA) is a unique suicide reduction&#xD;
      intervention that directly targets high-risk patients at the time of hospital discharge. It&#xD;
      is one of the few empirically-developed and promising interventions (e.g., strong pilot data)&#xD;
      for individuals hospitalized for suicide behavior.&#xD;
&#xD;
      The primary objective of this study is to test the efficacy of the CLASP intervention&#xD;
      compared to a treatment as usual plus Safety Assessment and Follow-up Evaluation (SAFE)&#xD;
      control condition. Efficacy will be determined by primary outcomes including: number of&#xD;
      attempts, number of re-hospitalizations, severity, and chronicity of suicidal ideation. A&#xD;
      secondary objective is identifying the types of patients who receive the most benefit from&#xD;
      the CLASP-VA intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 24, 2014</start_date>
  <completion_date type="Actual">August 29, 2018</completion_date>
  <primary_completion_date type="Actual">August 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior</measure>
    <time_frame>baseline, 3, 6, 9, &amp; 12 month post-hospitalization</time_frame>
    <description>Items measuring attempt behavior (number of Actual Attempts, number of Aborted Attempts, number of Interrupted Attempts) From the Columbia Suicide Severity Rating Scale were summed to create a composite variable indexing attempt behavior. Higher scores indicate more attempt behavior. We log transformed this variable at all time points to meet assumptions of normality.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Beck Hopelessness Scale</measure>
    <time_frame>Baseline, 3, 6, 9, &amp; 12 month follow up</time_frame>
    <description>The Beck Hopelessness Scale was used to measure changes in hopelessness from baseline to 12-month followup. Items are dichotomous (0: False and 1: True), with a total score ranging from 0-20. Higher scores indicate greater hopelessness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Symptom Inventory</measure>
    <time_frame>Baseline, 3, 6, 9, &amp; 12 month follow up</time_frame>
    <description>The Brief Symptom Inventory is a validated, self-reported instrument assessing current psychiatric symptomatology. Possible scores for each item range from 0 (not at all) to 4 (extremely), and total scores are represented by a Global Severity Index (range 0 to 212).Higher scores indicate greater psychological distress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>World Health Organization Disability Assessment Schedule (WHODAS) II</measure>
    <time_frame>Baseline, 3, 6, 9, &amp; 12 month follow ups</time_frame>
    <description>The World Health Organization Disability Assessment Schedule (WHODAS II) is a validated, self-reported instrument assessing current impairment in functioning. Possible scores for each item range from 1 (None) to 5 (Extreme or cannot do). We calculated an Average Global Score for inclusion in analyses by dividing the total score by the number of items included in the measure (possible range of 1-5). Higher scores indicate greater impairment in functioning. We examined changes in overall functioning from baseline in these analyses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment History Interview</measure>
    <time_frame>3, 6, 9, &amp; 12 month follow up</time_frame>
    <description>We used an item measuring psychiatric hospitalizations from the Treatment History Interview to measure treatment utilization. Study participants indicated how many times they had been psychiatrically hospitalized since the prior study timepoint. We log transformed this variable at each timepoint to meet statistical assumptions of normality for our analyses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Ideation Severity</measure>
    <time_frame>baseline, 3, 6, 9, &amp; 12 month post-hospitalization</time_frame>
    <description>Intensity of ideation was measured using the Columbia Scale for Suicide Ideation intensity of ideation item. Item responses range from 1 (wish to be dead) to 5 (active suicidal ideation with specific plan and intent), with higher scores indicating more severe ideation. Minimum score on the ideation measure is 1 and maximum score is 5.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">107</enrollment>
  <condition>Suicide</condition>
  <arm_group>
    <arm_group_label>CLASP Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Safety Assessment and follow up Evaluation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treatment as usual plus enhanced monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Coping Long Term with Active Suicide (CLASP)</intervention_name>
    <description>6 month behavioral telephone-based intervention. Calls assess risk, problem solve any immediate issues, and case management</description>
    <arm_group_label>CLASP Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Safety Assessment and Follow Up Evaluation</intervention_name>
    <description>enhanced risk monitoring with full assessment protocol at 3, 6, 9, and 12 month follow up. Results sent as a note to the patient's VA mental health provider</description>
    <arm_group_label>CLASP Intervention</arm_group_label>
    <arm_group_label>Safety Assessment and follow up Evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  suicide attempt or suicidal ideation with any methods, plan, and/or intent to make a&#xD;
             suicide attempt within 1 week of hospitalization&#xD;
&#xD;
          -  age greater than 18&#xD;
&#xD;
          -  have a telephone&#xD;
&#xD;
          -  ability to speak, read, and understand spoken English sufficiently well to complete&#xD;
             the procedures of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  long-term psychiatric disorder&#xD;
&#xD;
          -  diagnosis of borderline personality disorder&#xD;
&#xD;
          -  cognitive impairment which would interfere with adequate participation in the project&#xD;
             (MMSE &lt;20)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Marie Primack, PhD MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence VA Medical Center, Providence, RI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Providence VA Medical Center, Providence, RI</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 3, 2013</study_first_submitted>
  <study_first_submitted_qc>July 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2013</study_first_posted>
  <results_first_submitted>November 7, 2019</results_first_submitted>
  <results_first_submitted_qc>January 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 10, 2020</results_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>prevention</keyword>
  <keyword>Veterans health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 31, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT01894841/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 12, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT01894841/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from the Providence VA Medical center psychiatric inpatient unit</recruitment_details>
      <pre_assignment_details>One hundred and seven participants completed baseline assessments and were found to be eligible for the study. Two participants were lost prior to randomization since they could not be contacted by research staff.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CLASP Intervention</title>
          <description>The Coping Long Term with Active Suicide is a 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
        </group>
        <group group_id="P2">
          <title>Safety Assessment and Follow up Evaluation</title>
          <description>Treatment as usual plus enhanced monitoring condition consisting of assessment and medical record notes sent to mental health providers.&#xD;
Coping Long Term with Active Suicide: an intervention to reduce suicide behavior in Veterans recently hospitalized for suicide attempt or ideation with intent.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawn by investigator</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>2 participants completed screening and were enrolled but then were lost to contact prior to completing baseline measures.</population>
      <group_list>
        <group group_id="B1">
          <title>CLASP Intervention + Enhanced Monitoring</title>
          <description>A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.&#xD;
Plus&#xD;
Enhanced monitoring consisting of assessment and medical record notes sent to mental health providers.</description>
        </group>
        <group group_id="B2">
          <title>Safety Assessment and Follow up Evaluation + TAU</title>
          <description>Treatment as usual plus enhanced monitoring condition consisting of assessment and medical record notes sent to mental health providers.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="53"/>
            <count group_id="B3" value="105"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Demographics survey. Item asked for age of participant at the start of the study.</description>
          <population>2 participants were withdrawn from the study after enrollment and randomization prior to completing the baseline assessment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>2 participants were withdrawn from the study after enrollment and randomization prior to completing the baseline assessment.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.56" lower_limit="21" upper_limit="73"/>
                    <measurement group_id="B2" value="48.85" lower_limit="24" upper_limit="83"/>
                    <measurement group_id="B3" value="47.705" lower_limit="21" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>2 participants were withdrawn from the study after enrollment and randomization prior to completing the baseline assessment.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.56" spread="14.07"/>
                    <measurement group_id="B2" value="48.85" spread="14.76"/>
                    <measurement group_id="B3" value="47.74" spread="14.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>2 participants were withdrawn from the study after enrollment and randomization prior to completing the baseline assessment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>2 participants in the CLASP condition failed to complete baseline measures.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="52"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beck Hopelessness Scale</title>
          <description>The Beck Hopelessness Scale was used to measure changes in hopelessness from baseline to 12-month followup. Items are dichotomous (0: False and 1: True), with a total score ranging from 0-20. Higher scores indicate greater hopelessness.</description>
          <population>In the CLASP condition, 2 participants completed screening and were enrolled but then were lost to contact prior to completing baseline measures. An additional 2 failed to complete the full BHI&#xD;
2 participants in the SAFE condition did not complete the BHI</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="51"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.98" spread="5.69"/>
                    <measurement group_id="B2" value="12.96" spread="5.53"/>
                    <measurement group_id="B3" value="12.97" spread="5.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Columbia Suicide Severity Rating Scale -Ideation</title>
          <description>Intensity of ideation was measured using the Columbia Scale for Suicide Ideation intensity of ideation item. Item responses range from 1 (wish to be dead) to 5 (active suicidal ideation with specific plan and intent), with higher scores indicating more severe ideation.</description>
          <population>2 participants completed screening and were enrolled but then were lost to contact prior to completing baseline measures.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.28" spread=".730"/>
                    <measurement group_id="B2" value="4.26" spread=".836"/>
                    <measurement group_id="B3" value="4.27" spread=".782"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Columbia Suicide Severity Rating Scale - Attempt Behavior</title>
          <description>Items measuring attempt behavior (number of Actual Attempts, number of Aborted Attempts, number of Interrupted Attempts) From the Columbia Suicide Severity Rating Scale were summed to create a composite variable indexing attempt behavior. Higher scores indicate more attempt behavior.</description>
          <population>2 participants completed screening and were enrolled but then were lost to contact prior to completing baseline measures.</population>
          <units>Suicide attempts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="53"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.40" spread="1.76"/>
                    <measurement group_id="B2" value="1.55" spread="2.06"/>
                    <measurement group_id="B3" value="1.48" spread="1.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>WHODAS</title>
          <description>The World Health Organization Disability Assessment Schedule (WHODAS II) is a validated, self-reported instrument assessing current impairment in functioning. Possible scores for each item range from 1 (None) to 5 (Extreme or cannot do). We calculated an Average Global Score for inclusion in analyses by dividing the total score by the number of items included in the measure (possible range of 1-5). Higher scores indicate greater impairment in functioning.</description>
          <population>2 participants in CLASP condition were lost prior to baseline completion and 2 additional participants failed to complete the WHODAS&#xD;
3 participants in the control condition failed to complete the full WHODAS</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="98"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93.02" spread="21.84"/>
                    <measurement group_id="B2" value="92.78" spread="23.67"/>
                    <measurement group_id="B3" value="92.90" spread="22.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Brief Symptom Inventory</title>
          <description>The Brief Symptom Inventory is a validated, self-reported instrument assessing current psychiatric symptomatology. Possible scores for each item range from 0 (not at all) to 4 (extremely), and total scores are represented by a Global Severity Index (range 0 to 212). Higher scores indicate greater psychological distress.</description>
          <population>2 participants in the CLASp condition were lost prior to completing baseline measures.&#xD;
In the SAFE condition, 1 participant had missing data on the BSI</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="52"/>
                    <count group_id="B3" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.02" spread=".67"/>
                    <measurement group_id="B2" value="1.99" spread=".68"/>
                    <measurement group_id="B3" value="2.00" spread=".68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior</title>
        <description>Items measuring attempt behavior (number of Actual Attempts, number of Aborted Attempts, number of Interrupted Attempts) From the Columbia Suicide Severity Rating Scale were summed to create a composite variable indexing attempt behavior. Higher scores indicate more attempt behavior. We log transformed this variable at all time points to meet assumptions of normality.</description>
        <time_frame>baseline, 3, 6, 9, &amp; 12 month post-hospitalization</time_frame>
        <population>The sample sizes used in this analysis are smaller than the full samples recruited per group because of dropout from baseline to 1 year followup.</population>
        <group_list>
          <group group_id="O1">
            <title>CLASP Intervention</title>
            <description>A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
          </group>
          <group group_id="O2">
            <title>Safety Assessment and Follow up Evaluation</title>
            <description>Treatment as usual plus enhanced monitoring.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior</title>
          <description>Items measuring attempt behavior (number of Actual Attempts, number of Aborted Attempts, number of Interrupted Attempts) From the Columbia Suicide Severity Rating Scale were summed to create a composite variable indexing attempt behavior. Higher scores indicate more attempt behavior. We log transformed this variable at all time points to meet assumptions of normality.</description>
          <population>The sample sizes used in this analysis are smaller than the full samples recruited per group because of dropout from baseline to 1 year followup.</population>
          <units>log(attempts)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.16"/>
                    <measurement group_id="O2" value="0.18" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.30"/>
                    <measurement group_id="O2" value="0.05" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.15"/>
                    <measurement group_id="O2" value="0.01" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.22"/>
                    <measurement group_id="O2" value="0.03" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.17"/>
                    <measurement group_id="O2" value="0.03" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.13</p_value>
            <p_value_desc>Adjusted for change in depression from baseline to 1yr (measured via QIDS).</p_value_desc>
            <method>RMANOVA</method>
            <param_type>Partial eta squared</param_type>
            <param_value>.03</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Beck Hopelessness Scale</title>
        <description>The Beck Hopelessness Scale was used to measure changes in hopelessness from baseline to 12-month followup. Items are dichotomous (0: False and 1: True), with a total score ranging from 0-20. Higher scores indicate greater hopelessness.</description>
        <time_frame>Baseline, 3, 6, 9, &amp; 12 month follow up</time_frame>
        <population>2 participants from the CLASP condition were withdrawn from the study after enrollment and randomization prior to completing the baseline assessment. Number of participants analyzed is smaller per group due to dropout from baseline to 12 month follow-up and missing data for some time points.</population>
        <group_list>
          <group group_id="O1">
            <title>CLASP Intervention</title>
            <description>A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
          </group>
          <group group_id="O2">
            <title>Safety Assessment and Follow up Evaluation</title>
            <description>Treatment as usual plus enhanced monitoring.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Beck Hopelessness Scale</title>
          <description>The Beck Hopelessness Scale was used to measure changes in hopelessness from baseline to 12-month followup. Items are dichotomous (0: False and 1: True), with a total score ranging from 0-20. Higher scores indicate greater hopelessness.</description>
          <population>2 participants from the CLASP condition were withdrawn from the study after enrollment and randomization prior to completing the baseline assessment. Number of participants analyzed is smaller per group due to dropout from baseline to 12 month follow-up and missing data for some time points.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.65" spread="5.62"/>
                    <measurement group_id="O2" value="13.21" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.12" spread="6.59"/>
                    <measurement group_id="O2" value="9.28" spread="7.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.06" spread="7.50"/>
                    <measurement group_id="O2" value="9.28" spread="6.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.65" spread="7.13"/>
                    <measurement group_id="O2" value="7.31" spread="6.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.00" spread="6.78"/>
                    <measurement group_id="O2" value="7.58" spread="6.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.79</p_value>
            <method>RMANOVA</method>
            <method_desc>Adjusted for change in depression from baseline to 1yr (measured via QIDS).</method_desc>
            <param_type>Partial eta squared</param_type>
            <param_value>.01</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Brief Symptom Inventory</title>
        <description>The Brief Symptom Inventory is a validated, self-reported instrument assessing current psychiatric symptomatology. Possible scores for each item range from 0 (not at all) to 4 (extremely), and total scores are represented by a Global Severity Index (range 0 to 212).Higher scores indicate greater psychological distress.</description>
        <time_frame>Baseline, 3, 6, 9, &amp; 12 month follow up</time_frame>
        <population>There are fewer subjects in this analysis than were recruited for both groups at baseline due to dropout across timepoints.</population>
        <group_list>
          <group group_id="O1">
            <title>CLASP Intervention</title>
            <description>The Coping Long Term with Active Suicide is a 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
          </group>
          <group group_id="O2">
            <title>Safety Assessment and Follow up Evaluation</title>
            <description>Treatment as usual plus enhanced monitoring condition consisting of assessment and medical record notes sent to mental health providers.</description>
          </group>
        </group_list>
        <measure>
          <title>Brief Symptom Inventory</title>
          <description>The Brief Symptom Inventory is a validated, self-reported instrument assessing current psychiatric symptomatology. Possible scores for each item range from 0 (not at all) to 4 (extremely), and total scores are represented by a Global Severity Index (range 0 to 212).Higher scores indicate greater psychological distress.</description>
          <population>There are fewer subjects in this analysis than were recruited for both groups at baseline due to dropout across timepoints.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.93" spread="0.68"/>
                    <measurement group_id="O2" value="1.98" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.30" spread="0.90"/>
                    <measurement group_id="O2" value="1.17" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" spread="0.84"/>
                    <measurement group_id="O2" value="1.23" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="0.75"/>
                    <measurement group_id="O2" value="1.10" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.08" spread="0.90"/>
                    <measurement group_id="O2" value="1.06" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.49</p_value>
            <p_value_desc>Adjusted for change in depression from baseline to 1yr (measured via QIDS).</p_value_desc>
            <method>RMANOVA</method>
            <param_type>Partial eta squared</param_type>
            <param_value>.02</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>World Health Organization Disability Assessment Schedule (WHODAS) II</title>
        <description>The World Health Organization Disability Assessment Schedule (WHODAS II) is a validated, self-reported instrument assessing current impairment in functioning. Possible scores for each item range from 1 (None) to 5 (Extreme or cannot do). We calculated an Average Global Score for inclusion in analyses by dividing the total score by the number of items included in the measure (possible range of 1-5). Higher scores indicate greater impairment in functioning. We examined changes in overall functioning from baseline in these analyses.</description>
        <time_frame>Baseline, 3, 6, 9, &amp; 12 month follow ups</time_frame>
        <population>The number of participants in this analysis per group is smaller than was recruited at baseline due to dropout across time points.</population>
        <group_list>
          <group group_id="O1">
            <title>CLASP Intervention</title>
            <description>The Coping Long Term with Active Suicide is a 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
          </group>
          <group group_id="O2">
            <title>Safety Assessment and Follow up Evaluation</title>
            <description>Treatment as usual plus enhanced monitoring condition consisting of assessment and medical record notes sent to mental health providers.</description>
          </group>
        </group_list>
        <measure>
          <title>World Health Organization Disability Assessment Schedule (WHODAS) II</title>
          <description>The World Health Organization Disability Assessment Schedule (WHODAS II) is a validated, self-reported instrument assessing current impairment in functioning. Possible scores for each item range from 1 (None) to 5 (Extreme or cannot do). We calculated an Average Global Score for inclusion in analyses by dividing the total score by the number of items included in the measure (possible range of 1-5). Higher scores indicate greater impairment in functioning. We examined changes in overall functioning from baseline in these analyses.</description>
          <population>The number of participants in this analysis per group is smaller than was recruited at baseline due to dropout across time points.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" spread="0.55"/>
                    <measurement group_id="O2" value="2.54" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.12" spread="0.78"/>
                    <measurement group_id="O2" value="2.09" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.17" spread="0.72"/>
                    <measurement group_id="O2" value="2.07" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.00" spread="0.61"/>
                    <measurement group_id="O2" value="1.93" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.08" spread="0.82"/>
                    <measurement group_id="O2" value="2.04" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.96</p_value>
            <p_value_desc>Adjusted for change in depression from baseline to 1yr (measured via QIDS).</p_value_desc>
            <method>RMANOVA</method>
            <param_type>Partial eta-squared</param_type>
            <param_value>.003</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment History Interview</title>
        <description>We used an item measuring psychiatric hospitalizations from the Treatment History Interview to measure treatment utilization. Study participants indicated how many times they had been psychiatrically hospitalized since the prior study timepoint. We log transformed this variable at each timepoint to meet statistical assumptions of normality for our analyses.</description>
        <time_frame>3, 6, 9, &amp; 12 month follow up</time_frame>
        <population>The number of participants in this analysis per group is smaller than was recruited at baseline due to dropout across time points.</population>
        <group_list>
          <group group_id="O1">
            <title>CLASP Intervention</title>
            <description>The Coping Long Term with Active Suicide is a 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
          </group>
          <group group_id="O2">
            <title>Safety Assessment and Follow up Evaluation</title>
            <description>Treatment as usual plus enhanced monitoring condition consisting of assessment and medical record notes sent to mental health providers.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment History Interview</title>
          <description>We used an item measuring psychiatric hospitalizations from the Treatment History Interview to measure treatment utilization. Study participants indicated how many times they had been psychiatrically hospitalized since the prior study timepoint. We log transformed this variable at each timepoint to meet statistical assumptions of normality for our analyses.</description>
          <population>The number of participants in this analysis per group is smaller than was recruited at baseline due to dropout across time points.</population>
          <units>log(psychiatric hospitalizations)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.20"/>
                    <measurement group_id="O2" value="0.07" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.09"/>
                    <measurement group_id="O2" value="0.06" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.10"/>
                    <measurement group_id="O2" value="0.06" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.13"/>
                    <measurement group_id="O2" value="0.07" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.62</p_value>
            <method>RMANOVA</method>
            <method_desc>Adjusted for change in depression from baseline to 1yr (measured via QIDS).</method_desc>
            <param_type>Partial eta squared</param_type>
            <param_value>0.01</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Ideation Severity</title>
        <description>Intensity of ideation was measured using the Columbia Scale for Suicide Ideation intensity of ideation item. Item responses range from 1 (wish to be dead) to 5 (active suicidal ideation with specific plan and intent), with higher scores indicating more severe ideation. Minimum score on the ideation measure is 1 and maximum score is 5.</description>
        <time_frame>baseline, 3, 6, 9, &amp; 12 month post-hospitalization</time_frame>
        <population>The sample sizes used in this analysis are smaller than the full samples recruited per group because of dropout from baseline to 1 year followup.</population>
        <group_list>
          <group group_id="O1">
            <title>CLASP Intervention + Enhanced Monitoring</title>
            <description>A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.&#xD;
Plus&#xD;
Enhanced monitoring consisting of assessment and medical record notes sent to mental health providers.</description>
          </group>
          <group group_id="O2">
            <title>Safety Assessment and Follow up Evaluation + TAU</title>
            <description>Treatment as usual plus enhanced monitoring condition consisting of assessment and medical record notes sent to mental health providers.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Ideation Severity</title>
          <description>Intensity of ideation was measured using the Columbia Scale for Suicide Ideation intensity of ideation item. Item responses range from 1 (wish to be dead) to 5 (active suicidal ideation with specific plan and intent), with higher scores indicating more severe ideation. Minimum score on the ideation measure is 1 and maximum score is 5.</description>
          <population>The sample sizes used in this analysis are smaller than the full samples recruited per group because of dropout from baseline to 1 year followup.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.88" spread="0.73"/>
                    <measurement group_id="O2" value="4.16" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.56" spread="1.78"/>
                    <measurement group_id="O2" value="2.47" spread="1.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.08" spread="1.91"/>
                    <measurement group_id="O2" value="1.66" spread="1.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" spread="1.91"/>
                    <measurement group_id="O2" value="1.38" spread="1.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month Followup</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.84" spread="1.89"/>
                    <measurement group_id="O2" value="1.25" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data for each participant was collected for 12 months following baseline assessments.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>CLASP Intervention</title>
          <description>A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.</description>
        </group>
        <group group_id="E2">
          <title>Safety Assessment and Follow up Evaluation</title>
          <description>Treatment as usual plus enhanced monitoring.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for medical condition</sub_title>
                <description>Pancreatitis</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Medical hospitalization</sub_title>
                <description>broken bones/fractures</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for suicide ideation or behavior</sub_title>
                <description>Psychiatric hospitalization for suicide ideation or behavior</description>
                <counts group_id="E1" events="19" subjects_affected="14" subjects_at_risk="52"/>
                <counts group_id="E2" events="13" subjects_affected="9" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Hospitalization for substance use disorders</sub_title>
                <description>Hospitalization for substance use disorder or detox</description>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Hospitalization for excarbation of psychiatric symptoms</sub_title>
                <description>Re-hospitalization for worsening of psychiatric symptoms such as PTSD or bipolar disorder</description>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="52"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The dropout rate from baseline to the final timepoint (12 months) led to small numbers of subjects analyzed per group. Some completers had missing data for interim follow-up assessments.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jennifer Primack</name_or_title>
      <organization>Providence VAMC</organization>
      <phone>401 273-7100 ext 6295</phone>
      <email>jennifer.primack@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

